FDA.reportPublic FDA data

Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations

RxCUI
2110513
RxNorm name
Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
Display name
Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
Full name
Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Wixela InhubFLUTICASONE PROPIONATE AND SALMETEROLBryant Ranch Prepack6a5e28ef-3bbb-43a6-b599-499b3c6076c92025-02-13Warnings, Adverse reactionsExact identifier
rxcui: 2110513
Wixela InhubFLUTICASONE PROPIONATE AND SALMETEROLMylan Pharmaceuticals Inc.3beef422-8a07-4a45-9ba6-414511e4b7e22022-08-29Warnings, Adverse reactionsExact identifier
rxcui: 2110513

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6a5e28ef-3bbb-43a6-b599-499b3c6076c9Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations [PSN] · 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] [SBD] · Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations [SY]3100These highlights do not include all the information needed to use WIXELA INHUB ® safely and effectively. See full prescribing information for WIXELA INHUB ® . WIXELA INHUB ® (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use Initial U.S. Approval: 200020250213
3beef422-8a07-4a45-9ba6-414511e4b7e2Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations [PSN] · 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] [SBD] · Wixela Inhub 250/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations [SY]36These highlights do not include all the information needed to use WIXELA INHUB ® safely and effectively. See full prescribing information for WIXELA INHUB ® . WIXELA INHUB ® (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use Initial U.S. Approval: 200020220829